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PURPOSE. To utilize optical coherence tomography (OCT) and OCT angiography (OCTA) to
describe alterations in the retinal and choriocapillaris vasculature following remote laser
photocoagulation. Lesions are classified on the basis of choriocapillaris alteration as evaluated
on en face OCTA.
METHODS. This was a retrospective, cross-sectional study analyzing 28 laser photocoagulation
scars from 8 patients treated for diabetic macular edema. All eyes were analyzed using a
combination of OCTA, en face and cross-sectional OCT, and fundus photography. Two masked
readers scored images for alterations at the level of the retinal pigment epithelium (RPE),
choroid, and choriocapillaris. Laser photocoagulation lesions were classified as deep if
choriocapillaris alteration was present on OCTA; lesions were classified as superficial if no
choriocapillaris alteration was present on OCTA.
RESULTS. Optical coherence tomography angiography was found to be useful for evaluation of
choriocapillaris alteration underlying regions of laser scarring. Of the 28 analyzed laser scars,
13 were classified as superficial and 15 were classified as deep.
CONCLUSIONS. Optical coherence tomography angiography can be used to visualize
choriocapillaris alterations associated with focal laser photocoagulation treatment.
Keywords: laser photocoagulation, OCT angiography
Laser photocoagulation was previously a mainstay of office-based therapy for retinal disorders such as diabetic macular
edema (DME), choroidal neovascularization (CNV), and retinal
vein occlusion (RVO). However, the introduction of multiple
antivascular endothelial growth factor (VEGF) agents, which
have been shown to result in improved visual outcomes, has
led to the decline of focal laser as a first-line therapy.1–5
Nevertheless, focal laser photocoagulation may still be pre-
ferred in select clinical scenarios such as extrafoveal CNV,
retinal artery macroaneurysms, and non-center-involved clini-
cally significant macular edema.6
Structural changes in the retina and choroid induced by laser
photocoagulation depend on laser parameters such as wave-
length, power, exposure time, and spot size; patient factors,
time interval following exposure, and individual physician
treatment preferences. Focal laser for DME typically consists of
small, light treatments applied either in a grid pattern over a
region of DME or to select microaneurysms. Due to the high
concentration of melanosomes, the RPE is the main target of
the incident laser applied to the retina. Histopathology of
autopsy eyes has demonstrated defects in the choriocapillaris
beneath retinal laser lesions secondary to photocoagulation for
proliferative diabetic retinopathy.7 These lesions have been
observed to expand circumferentially over time, especially in
the posterior pole, and enlargement of RPE atrophy can cause
significant, delayed visual loss.8–10 In animal models, spectral-
domain optical coherence tomography (SD-OCT) has been used
to visualize disruptions in the RPE caused by laser treatment, as
well as the subsequent proliferation of RPE cells associated
with the postlaser healing process.11,12 There are, however,
limited studies detailing the in vivo changes that occur in the
RPE and choriocapillaris following focal laser treatment.
Optical coherence tomography angiography (OCTA) enables
noninvasive, depth-resolved visualization of the retinal and
choroidal vasculature. Optical coherence tomography angiog-
raphy images are generated through a repeated B-scan protocol
whereby multiple B-scans are acquired in rapid succession from
the same tissue location. As such, structural and angiographic
data sets are intrinsically coregistered, allowing for simulta-
neous visualization of the structure and blood flow. Optical
coherence tomography angiography has its origins in Doppler
OCT, a set of phase-sensitive techniques that exploit the
Doppler shift that occurs when the OCT beam is scattered by
moving erythrocytes.13 Since then, a number of related OCT-
based techniques measuring the phase and intensity changes
imparted by moving erythrocytes have been proposed.14–20
Split-spectrum amplitude decorrelation angiography (SSADA),
the algorithm used in this study, is an intensity-based technique
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that partitions the spectrum into multiple subspectrums,
performs the repeated B-scan decorrelation separately for each
subspectrum, and then averages the results. Split-spectrum
ADA has been shown to increase the signal-to-noise ratio as
compared to the single-spectrum approach.19
The central aim of this study was to assess the hypothesis
that a combination of OCT and OCTA images can be used to
assess changes in the retinal and choroidal vasculature,
including the choriocapillaris, in patients who have a history
of remote laser photocoagulation. Furthermore, in the process
of assessing this hypothesis we developed a classification
scheme that partitions lesions into ‘‘superficial’’ and ‘‘deep’’
categories.
METHODS
Subjects
This was a retrospective cross-sectional study evaluating eyes
with a remote history of macular laser photocoagulation. The
study was performed at the New England Eye Center (Boston,
MA, USA), and the study protocol was approved by the Tufts
Medical Center Institutional Review Board (IRB). The research
adhered to the tenets of the Declaration of Helsinki and
complied with the Health Insurance Portability and Account-
ability Act of 1996. Written informed consent was obtained
before OCTA examination in accordance with the Tufts
Medical Center IRB.
Patients with active DME were excluded from the study;
patients with color fundus and/or en face images without
clearly identifiable laser photocoagulation lesions in the
macular region were also excluded. To distinguish between
true flow impairment and OCTA thresholding artifacts caused
by low OCT signals, en face OCTA images were jointly viewed
with en face and cross-sectional OCT images using ImageJ
(National Institutes of Health, Bethesda, MD, USA [in the public
domain]). This technique has been previously described.21,22
All lesions included in this study were a result of laser
photocoagulation treatments occurring at least 1.5 years prior
to OCTA imaging. A chart review was performed to determine
laser settings. Traditional Early Treatment Diabetic Retinopathy
Study (ETDRS) parameters were used with a spot diameter of
50 lm, exposure time of 0.1 seconds, and power of 50 to 150
mW.
OCTA System
Subjects were imaged at the New England Eye Center between
September 2014 and July 2015 on the RTVue XR Avanti
AngioVue OCTA system (Optovue, Inc., Fremont, CA, USA).
This spectral-domain system operates at 70,000 A-scans per
second and acquires OCTA volumes of 304 A-scans 3 304 A-
scans. The central wavelength of the device is 840 nm with an
axial resolution of 5 lm and a transverse resolution of 15 lm.
Qualitative Analysis
Two masked Boston Image Reading Center readers (EDC, EAN)
correlated the location of laser lesions on the color fundus
photographs, en face OCTA images, and en face and cross-
sectional OCT images. The OCTA images were manually
segmented and evaluated for changes at the level of the
choriocapillaris. The manual segmentation of the choriocapil-
laris was achieved by first viewing the choriocapillaris slab
segmentation automatically generated by the AngioVue soft-
ware. The position of this slab was manually adjusted by
scrolling up or down in the corresponding B-scan, and the slab
thickness was adjusted so as to minimize decorrelation tail
artifacts. The slab was considered to be at the level of the
choriocapillaris when the background of the slab (not
including the laser marks) was a dense, homogenous layer,
consistent with choriocapillaris morphology. En face structural
OCT images were automatically fit to the RPE contour using
the Optovue software. En face images were analyzed at the
level of the RPE and choroid; corresponding OCT B-scans were
also used to assess OCT signal levels.
Laser photocoagulation lesions were classified as deep if
OCTA showed choriocapillaris alterations (red circles, Figs. 1,
2), and superficial if no visible choriocapillaris alterations were
visible on OCTA (yellow circles, Figs. 1, 2).
Photocoagulation lesions were classified as having chorio-
capillaris alteration if the two readers agreed that OCTA
revealed a focal choriocapillaris alteration at the laser spot.
Retinal pigment epithelium changes were considered present if
the corresponding en face OCT and/or cross-sectional OCT
images, segmented at the level of the RPE, showed disruption
of the linear RPE above the area of choriocapillaris alteration.
RESULTS
Eight eyes with 28 laser lesions from prior focal laser for DME
in the macular region met the inclusion criteria for this study.
Baseline characteristics of the patients were as follows: mean
age was 65.3 6 6.8 years, 6 of 8 patients were male, and 5 of 8
patients were Caucasian. All focal laser treatments were
performed between 1.5 to 9 years (mean 3.9 6 2.7 years)
prior to OCTA imaging. Of the 28 laser lesions, 15 were
classified as deep and 13 as superficial lesions.
Notably, there were no visible retinal vascular changes on
OCTA in the superficial and deep plexuses of retinal
vasculature with manual and automated segmentation. Corre-
sponding OCT B-scans of the deep lesions showed destruction
and irregularity involving the retinal pigmented epithelium
(RPE), cone outer segment tip (COST) line, inner segment-
outer segment (IS/OS), outer limiting membrane (OLM), outer
nuclear layer (ONL), and, in some cases, outer plexiform layer
(OPL) (Figs. 1E, 2E). Superficial lesions showed less severe
structural changes, and alterations were visible only at the level
of the RPE, COST line, IS/OS, and OLM (Figs. 1F, 2F).
All superficial and deep lesions showed areas of increased
OCT signal on en face OCT segmented at the level of the
choroid; the areas associated with the deep lesions were larger
than those associated with the superficial lesions (Figs. 1C,
2C). Nine of the 13 superficial scars had both regions of low
and high OCT signal on en face OCT segmented at the level of
the RPE; the remaining 4 lesions were associated only with
increased OCT signal. All deep lesions had both regions of low
signal and regions of high signal on en face OCT segmented at
the level of the RPE (Figs. 1B, 2B).
DISCUSSION
Visualizing laser lesions with a combination of OCT and OCTA
showed focal RPE loss and choriocapillaris alteration associated
with regions previously treated with laser photocoagulation,
which is consistent with histopathology literature.7–10 Further-
more, OCTA showed that some laser lesions were associated
with choriocapillaris alterations while others were not, which
may suggest variations in laser energy delivered to the RPE.
Postmortem analysis of eyes treated with argon laser
photocoagulation for proliferative diabetic retinopathy have
found choriocapillaris filling defects. These changes, as seen on
antemortem fluorescein angiography, corresponded to histo-
pathologic disruption of the choriocapillaris associated with
fibrosis and nonperfusion.7,23
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The photoreceptor layer, RPE, and choriocapillaris are
known to have a mutualistic relationship, and histopathologic
studies of eyes with nonexudative age-related macular degen-
eration (AMD) have found that RPE atrophy is closely
associated with choriocapillaris degeneration.24,25 Changes in
the choriocapillaris underlying areas of RPE disruption have
also been observed in other diseases including exudative AMD,
Stargardt disease, and retinitis pigmentosa.26,27 In addition,
recent OCTA studies have suggested decreased choriocapillaris
vascular density associated with some diabetic patients, both
with and without retinopathy (DA Salz et al., manuscript
submitted, 2015). While it is possible that some of the
choriocapillaris changes seen in this study were caused by
diabetic damage and not laser treatment, the focal nature of the
alterations suggests otherwise.
Spectral-domain OCT findings on human and rabbit eyes
treated with panretinal laser photocoagulation (PRP) for
diabetic retinopathy have been previously reported. The
reported changes include reduced choroidal thickness, depres-
sion of the inner retinal surface corresponding to focal
shrinkage of the ONL, and destruction of the choriocapillaris,
RPE, photoreceptors, and outer portions of the retina.28,29 In
our study we found no depression of the retinal tissue above
superficial or deep lesions nor was there retinal thinning,
which is likely due to the remote history of laser treatment in
the study patients. The extended time period (median 3.65 6
2.9 years) between focal laser photocoagulation and OCTA
imaging may explain why both superficial and deep plexuses of
the retinal vasculature appeared unaffected. Previous studies
have shown that retinal morphology can be restored after laser
photocoagulation. Kriechbaum and associates30 used OCT to
monitor healing response of human eyes in vivo after PRP and
showed that after 3 to 6 months, lesions were characterized by
a stable defect in the RPE and the ONL remained thinned at the
lesion center.
Optical coherence tomography angiography enables nonin-
vasive, high-resolution imaging of the retinal and choroidal
vasculature.31–34 Of particular relevance to the current study is
the capability of OCTA to visualize the choriocapillaris, which,
when healthy, has a thin, dense, monolayer morphology.26
Optical coherence tomography angiography visualization of
the choriocapillaris is complicated by the possibility of
‘‘thresholding’’ artifacts. Thresholding occurs when regions
of the OCTA signal that are associated with low OCT signal
FIGURE 1. Multimodal imaging of superficial (yellow) and deep (red) laser photocoagulation lesions. (A) Fundus photograph and (B) en face
structural OCT segmented at the level of the RPE. (C) En face OCT segmented at the level of the choroid. (D) OCTA image segmented at the level of
the choriocapillaris. Deep lesions exhibit choriocapillaris alteration, while superficial lesions do not. (E) OCT B-scan from a deep laser mark shows
increased light penetration due to RPE disruption with overlying external neuroretinal atrophy. (F) OCT B-scan from a superficial laser mark shows
comparably mild RPE and IS/OS changes.
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levels (as determined by the coregistered OCT volume) are
assigned low (dark) pixel values. This thresholding step
introduces an ambiguity: Areas of low OCTA signal may be
caused by low flow, low OCT signal, or both. Areas of low OCT
signal are especially likely to occur beneath the RPE, due to its
melanin content; additionally, sensitivity roll-off in spectral-
domain OCT will also reduce the OCT signal toward the
bottom of the image (when using a standard imaging
configuration). Both of these factors make OCTA of the
choriocapillaris particularly susceptible to thresholding arti-
facts. To avoid misinterpretation, it is necessary to evaluate
OCTA images in conjunction with a combination of en face and
cross-sectional OCT images. Additionally, due to limitations of
the axial and lateral resolution of the AngioVue system, it is not
possible for the segmented choriocapillaris slab to consist of
solely choriocapillaris vessels; it may also include vessels from
adjacent choroidal layers. However, it is likely that the laser
photocoagulation induces damage not only in the choriocap-
illaris vessels but also in adjacent choroidal vessels.
The ability of OCTA to visualize choriocapillaris alterations
suggests that a combination of OCT and OCTA may be useful
for titrating laser power so as to reduce the probability of
retinal and choroidal damage, as well as permanent disorgani-
zation and scarring in the photoreceptor layer. Strategies such
as micropulse laser have been developed that may minimize
tissue damage, especially in the macula.12,35 Recently, Koinzer
and associates36 demonstrated in an animal model that
automatic, temperature-controlled laser photocoagulation can
predictably induce subvisible, mild, or moderate lesions
without manual power titration. Application of fundus
temperature measurements during laser photocoagulation
would enable clinicians to perform laser photocoagulation
while minimizing damage to retinal tissue.17,36
FIGURE 2. Multimodal imaging of superficial (yellow) and deep (red) laser photocoagulation lesions. (A) Fundus photograph and (B) en face
structural OCT segmented at the level of the RPE. (C) En face OCT segmented at the level of the choroid. (D) Optical coherence tomography
angiography image segmented at the level of the choriocapillaris. Deep lesions exhibit choriocapillaris alteration, while superficial lesions do not.
(E) Optical coherence tomography B-scan from a deep laser mark shows increased light penetration due to RPE disruption with overlying external
neuroretinal atrophy. (F) Optical coherence tomography B-scan from a superficial laser mark shows comparably mild RPE changes, indicated by
increased signal penetration, and IS/OS and ELM changes.
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The repeated B-scan protocol required for OCTA imaging
limits the size of the field of view; the system used in this study
is able to generate OCTA images of up to 6 3 6 mm. It is
important to note that larger field sizes correspond to sparser
sampling, which can be problematic, particularly when one is
trying to interpret the choriocapillaris vasculature. The limited
field of views on commercial OCTA systems prevents the
acquisition of a single OCTA image covering the entire region
of laser treatment. This limitation can be, in part, overcome by
forming montages from multiple OCTA images. However,
montage-based approaches result in significantly increased
acquisition times because multiple smaller field-of-view OCTA
images must be acquired in an overlapping fashion.37,38
Moving forward, advances in high-speed imaging systems will
likely enable wide-field OCTA imaging while maintaining
clinically feasible imaging times; for example, Blatter et al.39
have described a high-speed swept-source OCT system capable
of generating ~488 OCTA images from a single acquisition.
As we have tried to emphasize throughout this paper,
caution should be exercised when interpreting OCTA images,
particularly when visualizing vasculature lying beneath the
RPE, such as the choriocapillaris. In addition to the previously
discussed thresholding artifacts, there are a variety of other
artifacts that merit consideration; these include the limited
ability of OCTA to visualize low flow vessels, segmentation-
related errors when viewing en face OCTA images, and artifacts
resulting from patient motion. As a thorough discussion of
OCTA artifacts is beyond the scope of this paper, we refer the
reader to the study by Spaide et al.21 for a detailed discussion.
The results of our current study are twofold. First, we
demonstrated that OCTA can be used to visualize choriocap-
illaris alterations associated with laser scars. Second, we found
that laser scars can be partitioned into two categories: deep
laser scars, which have associated choriocapillaris alteration,
and superficial laser scars, which have no associated chorio-
capillaris alteration. These results suggest that OCTA may
develop into a useful tool for assessing choriocapillaris
alteration resulting from focal laser photocoagulation.
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